MJH Studios™, a world-class production facility and resource center dedicated to the creation and distribution of original content, was recently featured in Post Magazine. The article highlights the successful growth of the studio and its ability to offer a superior digital experience to healthcare professionals.
CURE® magazine is once again recognizing top oncology nurses through its Extraordinary Healer® Award. These individuals epitomize exemplary compassion and expertise in patient care. The final day to submit nominations is January 1, 2018.
OncLive®, a leading digital provider of resources and information to oncology professionals, spoke with renowned oncologists on the importance of nominating and recognizing individuals in the oncology field.
CURE Media Group, the nation’s leading consumer digital and print media enterprise focused entirely on patients with cancer, honored eight individuals who have made a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs). The celebration event will be held today at the Georgia Aquarium in Atlanta.
CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients with cancer, has added The CLL Society, which serves the Chronic Lymphocytic Leukemia community, to its Strategic Alliance Partnership (SAP) Program. Michael J. Hennessy Jr., president of Michael J. Hennessy Associates, Inc., parent company of CURE Media Group, announced the program expansion.
OncLive®, a leading digital provider of resources and information for oncology professionals, presents the latest State of the Science Summit™ on Hematologic Malignancies at the W Hotel San Francisco on Dec. 16 from 9:00 a.m. to 1:00 p.m. The summit will follow the Annual Meeting and Exposition in Atlanta, Georgia, which is being held Dec. 9-12. The program will be chaired by Thomas G. Martin, M.D., clinical professor of medicine, Adult Leukemia and Bone Marrow Transplantation Program, and associate director, Myeloma Program, UCSF; co-leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center.